Dyne Therapeutics Inc (DYN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 66,736 | 45,464 | 40,145 | 42,279 | 52,755 |
| Operating Income | -66,736 | -45,464 | -40,145 | -42,279 | -52,755 |
| Other Income | 1,834 | 1,277 | 1,318 | 894 | 451 |
| Pre-tax Income | -64,902 | -44,187 | -38,827 | -41,385 | -52,304 |
| Net Income Continuous | -64,902 | -44,187 | -38,827 | -41,385 | -52,304 |
| Net Income | $-64,902 | $-44,187 | $-38,827 | $-41,385 | $-52,304 |
| EPS Basic Total Ops | -1.08 | -0.78 | -0.73 | -0.80 | -1.01 |
| EPS Basic Continuous Ops | -1.08 | -0.78 | -0.73 | -0.80 | -1.01 |
| EPS Diluted Total Ops | -1.08 | -0.78 | -0.73 | -0.80 | -1.01 |
| EPS Diluted Continuous Ops | -1.08 | -0.78 | -0.73 | -0.80 | -1.01 |
| EBITDA(a) | $-66,667 | $-45,233 | $-39,716 | $-41,645 | $-51,889 |